Your browser is no longer supported. Please, upgrade your browser.
DXCM [NASD]
DexCom, Inc.
Index- P/E- EPS (ttm)-0.30 Insider Own2.50% Shs Outstand77.51M Perf Week-5.71%
Market Cap4.71B Forward P/E153.00 EPS next Y0.40 Insider Trans-31.96% Shs Float74.91M Perf Month0.25%
Income-22.40M PEG- EPS next Q-0.10 Inst Own97.80% Short Float3.32% Perf Quarter19.78%
Sales259.20M P/S18.16 EPS this Y28.60% Inst Trans-1.05% Short Ratio4.06 Perf Half Y34.44%
Book/sh1.83 P/B33.19 EPS next Y3870.00% ROA-14.70% Target Price67.00 Perf Year31.36%
Cash/sh1.08 P/C56.32 EPS next 5Y32.50% ROE-20.10% 52W Range28.09 - 64.64 Perf YTD10.34%
Dividend- P/FCF636.21 EPS past 5Y24.30% ROI-14.90% 52W High-6.03% Beta0.43
Dividend %- Quick Ratio3.20 Sales past 5Y54.20% Gross Margin68.00% 52W Low116.23% ATR2.11
Employees646 Current Ratio3.60 Sales Q/Q63.10% Oper. Margin-8.30% RSI (14)48.01 Volatility4.10% 3.08%
OptionableYes Debt/Eq0.03 EPS Q/Q150.00% Profit Margin-8.60% Rel Volume1.03 Prev Close61.96
ShortableYes LT Debt/Eq0.02 EarningsFeb 25 AMC Payout- Avg Volume612.20K Price60.74
Recom2.00 SMA20-2.35% SMA502.86% SMA20031.14% Volume614,800 Change-1.97%
Jan-27-15Reiterated Oppenheimer Perform $47 → $64
Aug-07-14Reiterated Canaccord Genuity Buy $40 → $48
Jun-17-14Reiterated Canaccord Genuity Buy $38 → $40
Jan-24-14Resumed Canaccord Genuity Buy $34 → $44
Jan-14-14Reiterated The Benchmark Company Buy $40 → $44
Nov-07-13Upgrade Northland Capital Under Perform → Market Perform
Oct-15-13Initiated The Benchmark Company Buy $37
Aug-12-13Reiterated Feltl & Co. Sell $16.50 → $18.25
Aug-08-13Reiterated Canaccord Genuity Buy $25 → $26
Jul-24-13Downgrade Northland Capital Outperform → Under Perform $17
Jun-13-13Downgrade Feltl & Co. Hold → Sell
Jun-10-13Downgrade Wunderlich Buy → Hold $20
Mar-13-13Reiterated Wunderlich Buy $18 → $20
Feb-25-13Reiterated Feltl & Co. Hold $14 → $15.50
Jan-14-13Reiterated Wunderlich Buy $15 → $18
Oct-18-12Initiated Northland Securities Market Perform $12
Jan-17-12Initiated Brean Murray Buy $12.50
Jan-11-12Downgrade MLV & Co Buy → Hold $9
Dec-29-11Initiated Wunderlich Buy $12
Dec-20-11Initiated MLV & Co Buy $11
Feb-27-15 07:08PM  10-K for DexCom, Inc. Company Spotlight
Feb-26-15 09:54AM  DexCom Reports Earnings in Q4, Top Line Surges Y/Y - Analyst Blog Zacks
Feb-25-15 05:57PM  DexCom tops 4Q profit forecasts AP
04:30PM  DexCom Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:08PM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Office EDGAR Online
04:01PM  DexCom, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results Business Wire
07:07AM  Q4 2014 DexCom Inc Earnings Release - After Market Close CCBN
Feb-24-15 08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
Feb-23-15 12:10PM  Will DexCom (DXCM) Loss Better Estimates this Earnings? - Analyst Blog Zacks
Feb-19-15 08:30AM  Dexcom Announces Continued Partnership with NASCAR Driver Ryan Reed Business Wire
Feb-18-15 08:36AM  Is a Surprise Coming for DexCom (DXCM) This Earnings Season? - Tale of the Tape Zacks
08:30AM  DexCom Schedules Fourth Quarter and Full Year 2014 Earnings Release and Conference Call for February 25, 2015 at 4:30 p.m. Eastern Time Business Wire
Feb-16-15 12:30PM  Medtronic (MDT) Likely to Beat Q3 Earnings Estimates - Analyst Blog Zacks
Feb-09-15 12:01PM  3 Med-Instrument Stocks Poised to Gain this Earnings Season - Earnings ESP Zacks
11:00AM  Will CVS Health's (CVS) Earnings Surprise this Season? - Analyst Blog Zacks
12:08AM  [$$] Smartwatch App Helps Track Glucose at The Wall Street Journal
Feb-08-15 09:06PM  Smartwatch App Helps Track Glucose at The Wall Street Journal
Feb-04-15 07:00AM  DexCom Inc. (DXCM): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-03-15 06:00AM  Jim Cramer's Top Stock Picks: FB AAPL HAR URI DXCM at TheStreet
Feb-02-15 07:08PM  Cramer Remix: Let me be clear on oil at CNBC
09:56AM  Cramer's Stop Trading: UAL, LUV & more CNBC
Jan-29-15 11:30AM  FDA gives investors another reason to like DexCom at MarketWatch
08:30AM  DexCom to Present at 4th Annual Leerink Partners Global Healthcare Conference Business Wire
Jan-28-15 04:35PM  FDA OKs DexCom Glucose Monitoring System with Share App - Analyst Blog Zacks
Jan-27-15 09:25AM  DexCom (DXCM) Worth Watching: Stock Moves 8.4% Higher - Tale of the Tape Zacks
Jan-26-15 08:00AM  FDA Approves Dexcom G4 Platinum Continuous Glucose Monitoring System with Share Business Wire +8.35%
Jan-23-15 04:44PM  First Medical App System to Monitor Glucose Cleared in U.S. at Bloomberg
Jan-15-15 02:02PM  Some of the Nasdaqs leading lights have begun to dim at MarketWatch
11:56AM  A 'tattoo' may end fingerpricks for diabetics at CNBC
Jan-14-15 05:45PM  DexCom Declares Preliminary Q4 '14 Revenues, Guides '15 - Analyst Blog Zacks
Jan-13-15 08:31AM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Jan-07-15 08:30AM  DexCom to Present at 33rd Annual J.P. Morgan Healthcare Conference Business Wire
Jan-05-15 08:30AM  Kevin Sayer Assumes Role of President and Chief Executive Officer; Terry Gregg Transitions to Role of Executive Chairman Business Wire
Dec-09-14 09:55AM  3 Medical Device Stocks to Buy as Obesity and Diabetes Epidemic Spreads at 24/7 Wall St.
Dec-03-14 04:54PM  DexCom CEO Terry Gregg Explains 50% YTD Stock Leap, Plans for 2015 at TheStreet
08:30AM  DexCom to Present at Oppenheimer 25th Annual Healthcare Conference Business Wire
Nov-25-14 04:16PM  DEXCOM INC Files SEC form 8-K/A, Change in Directors or Principal Officers EDGAR Online
08:30AM  DexCom to Present at 26th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-19-14 08:30AM  DEXCOM INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events EDGAR Online
08:30AM  DexCom Announces Appointment of Mark G. Foletta as Board Member Business Wire
Nov-14-14 01:04PM  DEXCOM INC Financials EDGAR Online Financials
Nov-11-14 01:10PM  DexCom Scales 52-Week High on Product Pipeline Strength Zacks
Nov-10-14 01:54PM  DexCom G4 Platinum Software Gains FDA Nod, Shares Surge Zacks +5.05%
06:36AM  Strength Seen in DexCom (DXCM): Stocks Gains 14.1% Zacks
Nov-08-14 07:07PM  10-Q for DexCom, Inc. Company Spotlight
Nov-07-14 06:06AM  Foundation Medicine Slumps: FMI Tumbles 9.6% in Session Zacks +14.12%
Nov-06-14 04:52PM  DexCom misses 3Q profit forecasts AP
04:07PM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:01PM  DexCom, Inc. Reports Third Quarter 2014 Financial Results Business Wire
08:30AM  FDA Approves Dexcom Software with Artificial Pancreas Algorithm Business Wire
07:07AM  Q3 2014 DexCom Inc Earnings Release - After Market Close CCBN
Oct-30-14 08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
Oct-23-14 08:30AM  DexCom Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 at 4:30 p.m. Eastern Time Business Wire
Oct-20-14 02:19PM  [$$] Dexcom's Remote Glucose-Monitoring Device Cleared at The Wall Street Journal
09:24AM  FDA Approves Dexcom SHARE, the First Remote Mobile Communications Device Used for Continuous Glucose Monitoring (CGM) Business Wire
Oct-06-14 05:03PM  DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Sep-27-14 12:06AM  [$$] Citizen Hackers Tinker With Medical Devices at The Wall Street Journal
Sep-26-14 07:19PM  [$$] Citizen Hackers Tinker With Medical Devices at The Wall Street Journal
05:31PM  [video] Citizen Hackers Modify Diabetes Device at MarketWatch
Sep-03-14 01:04PM  3 Stocks Dragging The Health Services Industry Downward at TheStreet
11:15AM  Insider Trading Alert - NATI, DXCM And CNC Traded By Insiders at TheStreet
Aug-25-14 05:50PM  [video] A sensor to swallow with your medicine at CNBC
Aug-22-14 04:05PM  Top Insider Sells Highlight: Dexcom Inc. Gurufocus
Aug-21-14 01:04PM  DXCM, HOLX And CYH, Pushing Health Services Industry Downward at TheStreet
Aug-14-14 12:00PM  DexCom Continues to Gain; Enters Data Integration Deal Zacks
Aug-07-14 11:10AM  DexCom Sees Narrower Q2 Loss; Revenues Top Estimates Zacks +13.61%
09:47AM  Trade-Ideas: DexCom (DXCM) Is Today's "Barbarian At The Gate" Stock at TheStreet
08:30AM  Dexcom Announces Data Integration Relationship with Asante Solutions, Makers of the Snap Insulin Pump Business Wire
Aug-06-14 04:30PM  DexCom Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:06PM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:01PM  DexCom, Inc. Reports Second Quarter 2014 Financial Results Business Wire
07:07AM  Q2 2014 DEXCOM INC Earnings Release - After Market Close CCBN
Aug-05-14 04:05PM  Insulet and Dexcom Agree to Develop a CGM-Integrated Personal Diabetes Manager Marketwired
Aug-01-14 12:05PM  Jay D. Miller, the President and CEO of IMRIS Inc. (IMRS), Interviews with The Wall Street Transcript Wall Street Transcript
Jul-31-14 08:30AM  DexCom to Present at Canaccord Genuity 34th Annual Growth Conference Business Wire -6.06%
06:00AM  'Mad Money' Lightning Round: Stay With Thermo Fisher Scientific at TheStreet
Jul-23-14 08:30AM  DexCom Schedules Second Quarter 2014 Earnings Release and Conference Call for August 6, 2014 at 4:30 p.m. Eastern Time Business Wire
Jul-18-14 01:10PM  5 New Medical Technologies For Diabetics Benzinga
Jul-07-14 08:30AM  DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Jun-16-14 02:30PM  DexCom Collaborates with Insulet Corporation Zacks +5.08%
12:00AM  Freedom for Diabetics as Bionic Pancreas Passes Testing at Bloomberg
Jun-15-14 09:00PM  Diabetics Get Freedom in Bionic Pancreas Real-World Trial at Bloomberg
Jun-13-14 04:01PM  DexComs Forthcoming Mobile App Platform to Integrate Data from Insulets OmniPod System Business Wire
Jun-05-14 09:17AM  Top Swing Trade Ideas for Thursday, June 5: DexCom, Conn's and More at TheStreet
Jun-04-14 05:15PM  [video] Health app space heats up at CNBC +7.06%
12:50PM  FDA Nod for DexCom's G4 PLATINUM System Zacks
08:30AM  DEXCOM INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-03-14 04:01PM  The first and only real-time professional CGM, the Dexcom G4® PLATINUM Professional Continuous Glucose Monitoring System (CGM) Receives FDA Approval Business Wire
May-27-14 08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
May-16-14 03:55PM  Why Jim Cramer Says Investors Should Watch DexCom (DXCM) Stock at TheStreet
11:45AM  [video] Jim Cramer on Why DexCom Could be a Good Portfolio Addition at TheStreet
11:37AM  The Bellwether We've Searched For at TheStreet
May-12-14 10:27AM  DexCom has a conference call hosted by JPMorgan at theflyonthewall.com
May-06-14 08:32AM  DexCom Misses, Sees Broader Q1 Loss Zacks
May-02-14 02:11PM  Why DexCom Inc. Shares Briefly Swooned at Motley Fool
May-01-14 08:55PM  DexCom's CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  DEXCOM INC Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  DexCom, Inc. Discusses Q1 2014 Results (Webcast) at Seeking Alpha
04:09PM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:01PM  DexCom, Inc. Reports First Quarter 2014 Financial Results Business Wire
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes DexCom G4 system, a continuous glucose monitoring system; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. DexCom, Inc. markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. The company was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Balo Andrew KEVP, Clinical, RegulatoryFeb 24Option Exercise9.807,50073,500157,756Feb 26 08:44 PM
Balo Andrew KEVP, Clinical, RegulatoryFeb 24Sale62.227,500466,637150,256Feb 26 08:44 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Feb 23Option Exercise7.7914,000109,060242,866Feb 25 06:18 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerFeb 23Option Exercise6.034,00024,120124,524Feb 25 06:21 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Feb 23Sale63.4314,000888,023228,866Feb 25 06:18 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerFeb 23Sale63.584,000254,334120,524Feb 25 06:21 PM
ROPER JESSSVP, CFOFeb 18Option Exercise7.636,00045,78087,812Feb 20 06:00 PM
ROPER JESSSVP, CFOFeb 18Sale61.887,000433,19280,812Feb 20 06:00 PM
MOY JEFFREYSVP, OperationsFeb 17Option Exercise9.805,04449,43187,336Feb 19 05:35 PM
MOY JEFFREYSVP, OperationsFeb 17Sale62.115,044313,29182,292Feb 19 05:35 PM
GREGG TERRANCE HExecutive ChairmanFeb 17Sale62.1915,000932,802566,389Feb 19 05:59 PM
Balo Andrew KEVP, Clinical, RegulatoryFeb 10Option Exercise9.807,50073,500157,756Feb 12 07:22 PM
Balo Andrew KEVP, Clinical, RegulatoryFeb 10Sale61.417,500460,607150,256Feb 12 07:22 PM
VALDES JORGE ACTOFeb 09Option Exercise13.458,244110,882126,992Feb 11 07:59 PM
LISTER JOHNSr. VP, General CounselFeb 09Option Exercise6.775,03934,125112,605Feb 11 08:06 PM
VALDES JORGE ACTOFeb 09Sale61.678,244508,380118,748Feb 11 07:59 PM
VALDES JORGE ACTOFeb 09Sale61.6792657,10373,683Feb 11 07:59 PM
LISTER JOHNSr. VP, General CounselFeb 09Sale61.665,039310,693110,018Feb 11 08:06 PM
MOY JEFFREYSVP, OperationsFeb 02Option Exercise9.805,00049,00087,964Feb 04 09:18 PM
MOY JEFFREYSVP, OperationsFeb 02Sale60.695,000303,42582,964Feb 04 09:18 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 26Option Exercise11.3310,532119,328239,398Jan 27 07:33 PM
Balo Andrew KEVP, Clinical, Regulatory &Jan 26Option Exercise8.3515,001125,303160,130Jan 28 09:10 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 26Sale62.1810,532654,886228,866Jan 27 07:33 PM
Balo Andrew KEVP, Clinical, Regulatory &Jan 26Sale59.2515,001888,739150,130Jan 28 09:10 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerJan 23Option Exercise6.034,00024,120123,950Jan 27 07:41 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 23Option Exercise7.7914,000109,060242,866Jan 27 07:33 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 23Sale57.7814,000808,926228,866Jan 27 07:33 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerJan 23Sale58.224,000232,864119,950Jan 27 07:41 PM
MOY JEFFREYSVP, OperationsJan 20Option Exercise9.805,00049,00087,292Jan 22 08:54 PM
ROPER JESSSVP, CFOJan 20Option Exercise7.636,00045,78087,342Jan 22 09:03 PM
MOY JEFFREYSVP, OperationsJan 20Sale57.585,000287,90682,292Jan 22 08:54 PM
ROPER JESSSVP, CFOJan 20Sale57.347,000401,35581,342Jan 22 09:03 PM
GREGG TERRANCE HExecutive ChairmanJan 15Sale57.8415,000867,561581,389Jan 20 06:53 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 13Option Exercise11.339,468107,272238,334Jan 14 06:36 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 13Sale62.229,468589,141228,866Jan 14 06:36 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 12Option Exercise11.3320,000226,600248,866Jan 14 06:36 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 12Sale59.1820,0001,183,538228,866Jan 14 06:36 PM
VALDES JORGE ACTOJan 09Sale58.5392654,19974,609Jan 12 08:49 PM
LISTER JOHNSr. VP, General CounselJan 08Option Exercise4.585,03923,079115,057Jan 12 08:36 PM
VALDES JORGE ACTOJan 08Option Exercise13.458,244110,882122,793Jan 12 08:49 PM
LISTER JOHNSr. VP, General CounselJan 08Sale57.425,039289,337110,018Jan 12 08:36 PM
VALDES JORGE ACTOJan 08Sale57.448,244473,494118,748Jan 12 08:49 PM
MOY JEFFREYSVP, OperationsJan 05Option Exercise9.805,00049,00087,292Jan 07 05:50 PM
MOY JEFFREYSVP, OperationsJan 05Sale55.275,000276,36882,292Jan 07 05:50 PM
Balo Andrew KSVP, Regulatory and ClinicalDec 26Option Exercise7.6310,00076,300160,130Dec 30 05:04 PM
Balo Andrew KSVP, Regulatory and ClinicalDec 26Sale55.2710,000552,687150,130Dec 30 05:04 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Dec 23Option Exercise7.6514,000107,117241,011Dec 24 03:08 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesDec 23Option Exercise6.034,00024,120123,950Dec 24 03:25 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Dec 23Sale54.6214,000764,733228,866Dec 24 03:08 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesDec 23Sale54.694,000218,778119,950Dec 24 03:25 PM
ROPER JESSVP, CFODec 18Option Exercise7.6311,00083,93094,342Dec 19 08:10 PM
ROPER JESSVP, CFODec 18Sale56.4312,000677,14782,342Dec 19 08:10 PM
LISTER JOHNSr. VP, General CounselDec 15Option Exercise4.584,00018,320110,018Dec 16 05:02 PM
GREGG TERRANCE HCEODec 15Option Exercise6.8525,000171,250420,626Dec 17 06:02 PM
GREGG TERRANCE HCEODec 15Sale53.2310,000532,279600,389Dec 17 06:02 PM
GREGG TERRANCE HCEODec 15Sale53.2325,0001,330,698395,626Dec 17 06:02 PM
LISTER JOHNSr. VP, General CounselDec 12Option Exercise4.581,7508,015107,768Dec 16 05:02 PM
SAYER KEVIN RPresident & COODec 12Sale53.9710,000539,700390,852Dec 16 05:00 PM
LISTER JOHNSr. VP, General CounselDec 12Sale53.553,079164,869106,018Dec 16 05:02 PM
Balo Andrew KSVP, Regulatory and ClinicalDec 11Option Exercise7.6310,00076,300160,130Dec 15 05:05 PM
Balo Andrew KSVP, Regulatory and ClinicalDec 11Sale55.4210,000554,195150,130Dec 15 05:05 PM
VALDES JORGE ACTODec 08Option Exercise7.2516,000116,000134,748Dec 10 04:54 PM
VALDES JORGE ACTODec 08Sale56.0316,000896,509118,748Dec 10 04:54 PM
TOPOL ERICDirectorDec 03Sale55.0020,0001,100,00083,116Dec 04 07:08 PM
GREGG TERRANCE HCEODec 02Option Exercise5.4925,000137,350410,626Dec 04 06:58 PM
GREGG TERRANCE HCEODec 02Sale53.1125,0001,327,778395,626Dec 04 06:58 PM
GREGG TERRANCE HCEONov 28Option Exercise8.5325,000213,250415,626Dec 01 07:36 PM
GREGG TERRANCE HCEONov 28Sale52.0225,0001,300,475395,626Dec 01 07:36 PM
GREGG TERRANCE HCEONov 26Option Exercise8.9534,990313,161430,616Dec 01 07:36 PM
GREGG TERRANCE HCEONov 26Sale51.1534,9901,789,854395,626Dec 01 07:36 PM
Balo Andrew KSVP, Regulatory and ClinicalNov 25Option Exercise7.6310,00076,300160,130Nov 26 05:24 PM
GREGG TERRANCE HCEONov 25Option Exercise8.9520,010179,090415,636Nov 26 05:30 PM
Balo Andrew KSVP, Regulatory and ClinicalNov 25Sale51.1110,000511,138150,130Nov 26 05:24 PM
GREGG TERRANCE HCEONov 25Sale51.0020,0101,020,510395,626Nov 26 05:30 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Nov 24Option Exercise12.5522,500282,345242,866Nov 26 04:55 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesNov 24Option Exercise6.034,00024,120123,950Nov 26 05:03 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesNov 24Option Exercise6.034,00024,120123,950Nov 26 05:19 PM
GREGG TERRANCE HCEONov 24Option Exercise8.9535,000313,250430,626Nov 26 05:30 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Nov 24Sale50.6422,5001,139,473228,866Nov 26 04:55 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesNov 24Sale50.364,000201,446119,950Nov 26 05:03 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesNov 24Sale50.364,000201,446119,950Nov 26 05:19 PM
GREGG TERRANCE HCEONov 24Sale51.0635,0001,787,030395,626Nov 26 05:30 PM
GREGG TERRANCE HCEONov 21Option Exercise8.9510,00089,500405,626Nov 24 04:45 PM
GREGG TERRANCE HCEONov 21Sale50.5010,000505,000395,626Nov 24 04:45 PM
GREGG TERRANCE HCEONov 19Option Exercise8.9510,00089,500405,626Nov 21 05:46 PM
GREGG TERRANCE HCEONov 19Sale51.0010,000510,000395,626Nov 21 05:46 PM
GREGG TERRANCE HCEONov 17Option Exercise6.8525,000171,250420,626Nov 18 06:12 PM
GREGG TERRANCE HCEONov 17Sale52.5225,0001,313,063395,626Nov 18 06:12 PM
GREGG TERRANCE HCEONov 17Sale52.5210,000525,225610,389Nov 18 06:12 PM
GREGG TERRANCE HCEONov 14Option Exercise8.9510,00089,500405,626Nov 18 06:12 PM
GREGG TERRANCE HCEONov 14Sale52.5110,000525,083395,626Nov 18 06:12 PM
GREGG TERRANCE HCEONov 12Option Exercise8.9525,000223,750420,626Nov 13 05:58 PM
LISTER JOHNSr. VP, General CounselNov 12Option Exercise4.581,7508,015110,425Nov 14 04:54 PM
GREGG TERRANCE HCEONov 12Sale54.0125,0001,350,350395,626Nov 13 05:58 PM
LISTER JOHNSr. VP, General CounselNov 12Sale52.813,078162,560107,347Nov 14 04:54 PM
ROPER JESSVP, CFONov 11Option Exercise7.6320,000152,600103,342Nov 13 05:45 PM
Balo Andrew KSVP, Regulatory and ClinicalNov 11Option Exercise7.6310,00076,300160,130Nov 13 05:51 PM
GREGG TERRANCE HCEONov 11Option Exercise8.9555,000492,250450,626Nov 13 05:58 PM
LORD JONATHAN T MDDirectorNov 11Option Exercise7.7818,058140,491155,165Nov 13 04:53 PM
MOY JEFFREYSVP, OperationsNov 11Option Exercise9.804,00039,20086,292Nov 13 05:38 PM